查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1632602

全球止血瓣膜市場：市場規模、佔有率及趨勢分析（按類型、應用、最終用途、地區及細分市場，2025-2030 年）

Hemostasis Valve Market Size, Share & Trends Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application (Angiography, Angioplasty), By End Use, By Region and Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

止血瓣膜市場規模及趨勢：

2024 年全球止血瓣膜市場規模估計為 1.846 億美元，預計 2025 年至 2030 年期間複合年成長率為 5.8%。

心血管疾病發病率的上升、支持性法律規範、老年人口的成長以及技術進步極大地推動了市場的成長。 《2024 年世界心臟報告》強調，空氣污染會加劇所有主要心血管疾病 (CVD)。 2019年，與環境空氣污染相關的420萬人死亡中，近70%是由於心血管問題，尤其是缺血性心臟疾病（190萬人死亡）和中風（90萬人死亡）。這增加了對血管造影術和血管成形術等診斷和治療程序的需求，而止血閥對於在導管手術期間控制血流和確保患者安全至關重要。

人們對微創手術的偏好日益增加也是推動市場成長的關鍵因素。微創手術比傳統開放性手術有許多優勢，包括疼痛更少、住院時間更短、恢復時間更快、併發症風險更低。因此，對於促進這些程序的醫療設備的需求日益增加。止血閥對於微創導管介入至關重要，因為它們可以精確控制血流並防止手術過程中洩漏。 2024 年 6 月發表在《心血管造影與介入學會雜誌》上的一篇論文討論了經股動脈經導管主動脈瓣置換術(TAVR) 期間的止血通常是如何透過使用縫合線使用血管閉合裝置 (VCD) 的預閉合技術來實現的。最近，引入了一種混合方法，當止血失敗時，在移除鞘套後加入膠原蛋白塞 VCD。

由於出生率下降和醫療保健進步導致的預期壽命增加，世界人口結構正在顯著地向老化轉變。根據世界衛生組織（WHO）的數據，到2050年，全球60歲以上人口預計將增加一倍，達到約21億人。這種人口結構的變化凸顯了老年人中與老齡化相關的疾病（包括心血管疾病（CVD））的盛行率不斷上升。根據美國心臟協會2023年11月發表的一篇論文，心臟衰竭是一種廣泛而多方面的心血管疾病，影響超過670萬美國，在65歲及以上的人群中尤為普遍。人口老化使得人們更容易患上心血管疾病，這推動了對診斷和治療程序的需求，從而推動了市場成長。

醫療設備的技術進步對於推動市場成長至關重要。材料、設計和功能的創新正在帶來更有效、更可靠的止血瓣膜。例如，先進的聚合物和塗層的使用使得這些裝置更加耐用和生物相容性，減少了血栓症和感染疾病等併發症。此外，易於使用的鎖定機制和增強的密封能力等新功能的加入提高了止血瓣在臨床實踐中的效率。例如，波士頓科學公司的 WATCHDOG 止血閥採用創新的十字縫設計，以最大限度地減少洩漏，並具有可同時容納多個設備的 8F 管腔。此外，它還配有拇指托，旨在提高手術過程中的舒適度。總的來說，這些設計元素有助於降低出血和空氣栓塞的風險，並在整個醫療干預過程中將患者安全放在首位。這些技術改進將使手術更加安全、高效，促進止血瓣膜的推廣應用。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

3. 止血瓣膜市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 止血閥市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析
    • 管道分析

第4章 止血瓣膜市場：按類型估計和趨勢分析

  • 全球止血閥市場：按類型分類的儀表板
  • 全球止血瓣膜市場：按類型進行差異分析
  • 全球止血瓣膜市場按類型分類（以收益為準）
  • 止血閥 Y 型連接器
  • 雙Y型止血閥
  • 單手止血閥
  • 其他

第 5 章止血瓣膜市場：按應用分類的估計和趨勢分析

  • 全球止血閥市場：按應用分類的儀表板
  • 全球止血瓣膜市場：按應用的變化分析
  • 全球止血瓣膜市場按應用分類（以收益為準）
  • 血管造影術
  • 血管成形術

第6章止血瓣膜市場：按最終用途分類的估計和趨勢分析

  • 全球止血閥市場：依最終用途分類的儀表板
  • 全球止血瓣膜市場：依最終用途的變化分析
  • 全球止血瓣膜市場按最終用途分類（以收益為準）
  • 醫院
  • 門診手術中心
  • 其他

第 7 章止血瓣膜市場：區域估計和趨勢分析（按國家、類型、應用和最終用途）

  • 區域控制面板
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 最新趨勢和影響分析：按主要製造商
  • 公司/競爭對手分類
  • 供應商概況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 主要企業市場佔有率分析（2024年）
  • 公司簡介
    • Boston Scientific Corporation
    • Teleflex Incorporated
    • Merit Medical Systems
    • B. Braun SE
    • Terumo Corporation
    • Abbott
    • Argon Medical Devices
    • Freudenberg Medical
    • SCW Medicath Ltd
    • Lepu Medical Technology（Beijing）Co.,Ltd.
    • Nipro
    • DeRoyal Industries, Inc.
    • Antmed Corporation
    • Beijing Demax Medical Technology Co
Product Code: GVR-4-68040-342-2

Hemostasis Valve Market Size & Trends:

The global hemostasis valve market size was estimated at USD 184.6 million in 2024 and is projected to grow at a CAGR of 5.8% from 2025 to 2030. The increasing prevalence of cardiovascular diseases, supportive regulatory frameworks, rising geriatric population, and technological advancements are significantly driving the market growth. The World Heart Report 2024 highlights that air pollution worsens all major cardiovascular diseases (CVDs). In 2019, nearly 70% of the 4.2 million deaths linked to ambient air pollution were due to cardiovascular issues, particularly ischaemic heart disease (1.9 million deaths) and stroke (900,000 deaths). This, in turn, drives the demand for diagnostic and therapeutic procedures like angiography and angioplasty, where hemostasis valves are essential to ensure patient safety by controlling blood flow during catheterization procedures.

The growing preference for minimally invasive procedures is another significant factor propelling the market growth. Minimally invasive techniques offer numerous benefits over traditional open surgeries, including reduced pain, shorter hospital stays, faster recovery times, and lower risk of complications. As a result, there is a heightened demand for medical devices that facilitate these procedures. Hemostasis valves are integral to minimally invasive catheter-based interventions, as they enable precise control of blood flow and prevent leakage during the procedure. In June 2024, an article in the Journal of the Society for Cardiovascular Angiography & Interventions discussed how hemostasis during transfemoral transcatheter aortic valve replacement (TAVR) is usually achieved with a suture-mediated vascular closure device (VCD) via a preclosure technique. Recently, a hybrid approach has been introduced, incorporating a collagen-plug VCD after sheath removal in cases where hemostasis fails.

The global demographic landscape is undergoing a notable shift towards aging, driven by declining birth rates and advancements in healthcare that have prolonged life expectancy. According to the World Health Organization (WHO), the number of people aged 60 years and older is expected to double by 2050, reaching approximately 2.1 billion globally. This demographic transition underscores the increasing prevalence of age-related conditions, including cardiovascular diseases (CVDs) among older adults. According to the article published by the American Heart Association in November 2023, heart failure is a widespread and multifaceted cardiovascular condition impacting more than 6.7 million Americans, particularly prevalent among individuals aged 65 and older. The aging population is susceptibility to cardiovascular diseases drive the demand for diagnostic and therapeutic procedures, driving the market growth.

Technological advancements in medical devices are pivotal in driving the market growth. Materials, design, and functionality innovations have developed more effective and reliable hemostasis valves. For instance, using advanced polymers and coatings has improved the durability and biocompatibility of these devices, reducing complications such as thrombosis and infection. In addition, incorporating novel features such as easy-to-use locking mechanisms and enhanced sealing capabilities has increased the efficiency of hemostasis valves in clinical settings. For instance, the WATCHDOG Hemostasis Valve by Boston Scientific Corporation incorporates an innovative cross-slit design to minimize leakage, complemented by an 8F inner lumen that simultaneously accommodates multiple devices. In addition, it includes a thumb rest feature designed for enhanced comfort during procedures. The design elements collectively contribute to reducing blood loss and the risk of air embolism, prioritizing patient safety throughout medical interventions. These technological improvements ensure that procedures are safer and more efficient, boosting the adoption of hemostasis valves.

Global Hemostasis Valve Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global hemostasis valve market report based on type, application, end-use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Hemostasis Valve Y- Connectors
  • Double Y- Connector Hemostasis Valves
  • One- Handed Hemostasis Valves
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Angiography
  • Angioplasty
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis Valve Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Growing demand for minimally invasive surgeries
      • 3.2.1.3. Improved healthcare infrastructure
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of hemostasis valves
      • 3.2.2.2. Regulatory hurdles
  • 3.3. Hemostasis Valve Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Hemostasis Valve Market: Type Estimates & Trend Analysis

  • 4.1. Global Hemostasis Valve Market: Type Dashboard
  • 4.2. Global Hemostasis Valve Market: Type Movement Analysis
  • 4.3. Global Hemostasis Valve Market by Type, Revenue
  • 4.4. Hemostasis Valve Y- Connectors
    • 4.4.1. Hemostasis valve Y- connectors market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Double Y- Connector Hemostasis Valves
    • 4.5.1. Double Y- connector hemostasis valves market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6. One- Handed Hemostasis Valves
    • 4.6.1. One - handed hemostasis valves market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Hemostasis Valve Market: Application Estimates & Trend Analysis

  • 5.1. Global Hemostasis Valve Market: Application Dashboard
  • 5.2. Global Hemostasis Valve Market: Application Movement Analysis
  • 5.3. Global Hemostasis Valve Market by Application, Revenue
  • 5.4. Angiography
    • 5.4.1. Angiography market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Angioplasty
    • 5.5.1. Angioplasty market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Hemostasis Valve Market: End Use Estimates & Trend Analysis

  • 6.1. Global Hemostasis Valve Market: End Use Dashboard
  • 6.2. Global Hemostasis Valve Market: End Use Movement Analysis
  • 6.3. Global Hemostasis Valve Market by End Use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Hemostasis Valve Market: Regional Estimates & Trend Analysis by Country, Type, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Boston Scientific Corporation
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Teleflex Incorporated
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Merit Medical Systems
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. B. Braun SE
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Terumo Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Abbott
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Argon Medical Devices
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Freudenberg Medical
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. SCW Medicath Ltd
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Lepu Medical Technology (Beijing)Co.,Ltd.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Nipro
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. DeRoyal Industries, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Antmed Corporation
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Beijing Demax Medical Technology Co
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 3 Global hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global hemostasis valve market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 30 France hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 31 France hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 52 China hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 53 China hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 58 India hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 59 India hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America hemostasis valve market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 83 South Africa hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 89 UAE hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE hemostasis valve market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait hemostasis valve market, by type, 2018 - 2030 (USD Million)
  • Table 92 Kuwait hemostasis valve market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait hemostasis valve market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Hemostasis valve market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Hemostasis Valve Market: Type Outlook Key Takeaways
  • Fig. 15 Global Hemostasis Valve Market: Type Movement Analysis
  • Fig. 16 Global Hemostasis Valve Y- Connectors Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Double Y- Connector Hemostasis Valves Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global One- Handed Hemostasis Valves Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Hemostasis Valve Market: Application Outlook Key Takeaways
  • Fig. 21 Global Hemostasis Valve Market: Application Movement Analysis
  • Fig. 22 Global Angiography Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Angioplasty Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Hemostasis Valve Market: End Use Outlook Key Takeaways
  • Fig. 25 Global Hemostasis Valve Market: End Use Movement Analysis
  • Fig. 26 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional outlook, 2024 & 2030
  • Fig. 31 Global Hemostasis Valve Market: Region Movement Analysis
  • Fig. 32 North America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia pacific Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 47 China Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 48 India Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 60 Strategy framework